Clinical features and quality of life in patients with different phenotypes of Crohn's disease of the ileal pouch

被引:53
作者
Shen, Bo
Fazio, Victor W.
Remzi, Feza H.
Bennett, Ana E.
Lavery, Ian C.
Lopez, Rocio
Brezinski, Aaron
Sherman, Kerry K.
Bambrick, Marlene L.
Lashner, Bret A.
机构
[1] Cleveland Clin, Dept Gastroenterol Hepatol Desk A31, Ctr Inflammatory Bowel Dis, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Colorectal Surg, Cleveland, OH 44195 USA
[3] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44195 USA
[4] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA
关键词
Crohn's disease; inflammatory bowel disease; ileal pouch; phenotypes; pouchitis; restorative proctocolectomy; ulcerative colitis;
D O I
10.1007/s10350-007-0284-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: Crohn's disease of the pouch can occur in patients with colectomy and ileal pouch-anal anastomosis performed for ulcerative colitis. The clinical features of inflammatory, fibrostenotic, and fistulizing Crohn's disease have not been characterized. METHODS: A total of 73 eligible patients with Crohn's disease of the pouch, who were seen in the Pouchitis Clinic, were enrolled: 25 with inflammatory Crohn's disease, 17 with fibrostenotic Crohn's disease, and 31 with fistulizing Crohn's disease. The clinical phenotypes of Crohn's disease were based on a combined assessment of clinical, endoscopic, radiographic, and histologic features. Clinical symptoms, endoscopic and histologic features, and health-related quality-of-life scores were assessed. RESULTS: Demographic and clinical features, including preoperative and postoperative parameters, were similar between the three phenotypes of Crohn's disease of the pouch. The use of nonsteroidal anti-inflammatory drugs, neuropsychiatric drugs, antidiarrheal agents, and Crohn's disease medicines was not different between the three groups. Predominant symptoms, as expected, were significantly different between the three phenotypes: diarrhea and/or pain in 92 percent of patients with inflammatory Crohn's disease, obstructive symptoms in 64.7 percent of patients with fibrostenotic Crohn's disease, and fistular drainage in 51.6 percent of those with fistulizing Crohn's disease (P < 0.0001). There was no statistical difference in quality-of-life scores between the three phenotypes, adjusted for disease activity. There was no significant correlation between quality-of-life and symptom scores in any of the three groups. Although not statistically significant, patients with fistulizing Crohn's disease (16.1 percent) tended to have an increased risk for pouch failure compared with inflammatory (8 percent) or fibrostenotic (5.9 percent) Crohn's disease. CONCLUSIONS: Predominant symptoms were different in clinical phenotypes of Crohn's disease. Each of the three phenotypes of Crohn's disease similarly affected quality-of-life. Fistulizing Crohn's disease may be associated with a higher risk for pouch failure.
引用
收藏
页码:1450 / 1459
页数:10
相关论文
共 49 条
  • [1] Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis
    Alexander, F
    Sarigol, S
    DiFiore, J
    Stallion, A
    Cotman, K
    Clark, H
    Lydzinski, B
    Fazio, V
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2003, 38 (01) : 78 - 82
  • [2] Andersson P, 2003, Colorectal Dis, V5, P56, DOI 10.1046/j.1463-1318.2003.00407.x
  • [3] Pre-pouch ileitis: a disease of the ileum in ulcerative colitis after restorative proctocolectomy
    Bell, AJ
    Price, AB
    Forbes, A
    Ciclitira, PJ
    Groves, C
    Nicholls, RJ
    [J]. COLORECTAL DISEASE, 2006, 8 (05) : 402 - 410
  • [4] Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life
    Casellas, F
    Vivancos, JL
    Sampedro, M
    Malagelada, JR
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (12) : 2737 - 2742
  • [5] Impairment of health-related quality of life in patients with inflammatory bowel disease:: A Spanish multicenter study
    Casellas, F
    Arenas, JI
    Baudet, JS
    Fábregas, S
    García, N
    Gelabert, J
    Medina, C
    Ochotorena, I
    Papo, M
    Rodrigo, L
    Malagelada, JR
    [J]. INFLAMMATORY BOWEL DISEASES, 2005, 11 (05) : 488 - 496
  • [6] Chhablani RK, 2004, GASTROENTEROLOGY, V126, pA630
  • [7] Management of Crohn's disease of the heoanal pouch with infliximab
    Colombel, JF
    Ricart, E
    Loftus, EV
    Tremaine, WJ
    Young-Fadok, T
    Dozois, EJ
    Wolff, BG
    Devine, R
    Pemberton, JH
    Sandborn, WJ
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (10) : 2239 - 2244
  • [8] Narcotic use in patients with Crohn's disease
    Cross, RK
    Wilson, KT
    Binion, DG
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (10) : 2225 - 2229
  • [9] Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis
    Delaney, CP
    Remzi, FH
    Gramlich, T
    Dadvand, B
    Fazio, VW
    [J]. ANNALS OF SURGERY, 2002, 236 (01) : 43 - 48
  • [10] RESULTS OF THE PELVIC-POUCH PROCEDURE IN PATIENTS WITH CROHNS-DISEASE
    DEUTSCH, AA
    MCLEOD, RS
    CULLEN, J
    COHEN, Z
    [J]. DISEASES OF THE COLON & RECTUM, 1991, 34 (06) : 475 - 477